Cart
sales@molnova.com
Graveoline
CAS No. 485-61-0
Graveoline( 2-(Benzo[d][1,3]dioxol-5-yl)-1-methylquinolin-4(1H)-one | Foliosine )
Catalog No. M24439 CAS No. 485-61-0
Graveoline is an apoptosis and autophagy inducer in skin melanoma cancer cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 44 | In Stock |
|
| 5MG | 40 | In Stock |
|
| 10MG | 57 | In Stock |
|
| 25MG | 93 | In Stock |
|
| 50MG | 133 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGraveoline
-
NoteResearch use only, not for human use.
-
Brief DescriptionGraveoline is an apoptosis and autophagy inducer in skin melanoma cancer cells.
-
DescriptionGraveoline is an apoptosis and autophagy inducer in skin melanoma cancer cells.
-
In Vitro——
-
In Vivo——
-
Synonyms2-(Benzo[d][1,3]dioxol-5-yl)-1-methylquinolin-4(1H)-one | Foliosine
-
PathwayAutophagy
-
TargetAutophagy
-
Recptorautophagy
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number485-61-0
-
Formula Weight279.29
-
Molecular FormulaC17H13NO3
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCN1C2=CC=CC=C2C(=O)C=C1C3=CC4=C(C=C3)OCO4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ghosh S, Bishayee K, Khuda-Bukhsh AR. Graveoline isolated from ethanolic extract of Ruta graveolens triggers apoptosis and autophagy in skin melanoma cells: a novel apoptosis-independent autophagic signaling pathway. Phytother Res. 2014;28(8):1153-1162. doi:10.1002/ptr.5107
molnova catalog
related products
-
Alisol A
Alisol A may be an autophagic inducer it has anti-cancer activity it presents inhibitory effects on cancer cell lines tested(HepG2 MDA-MB-231 and MCF-7 cells).
-
MDK-6983
MDK-6983 is an inhibitor of autophagy and disrupts the dynamics of actin cytoskeleton in human melanoma cells.
-
Pitavastatin
Pitavastatin (NK-104) is a potent inhibitor of hydroxymethylglutaryl-CoA (HMG-CoA) reductase, effectively inhibiting cholesterol synthesis from acetic acid in HepG2 cells with an IC50 of 5.8 nM.
